APA (7th ed.) Citation

Sever, B., Türkeş, C., Demir, Y., Elamin, K. M., Osman, W., Oral, K., . . . Ciftci, H. (2026). Hydrazonylthiazole Derivatives as Dual EGFR and ALR2 Inhibitors: Design, Synthesis, and Comprehensive In Vitro and In Silico Evaluation for Potential Anticancer Activity. Pharmaceuticals (14248247), 19(1), 50. https://doi.org/10.3390/ph19010050

Chicago Style (17th ed.) Citation

Sever, Belgin, et al. "Hydrazonylthiazole Derivatives as Dual EGFR and ALR2 Inhibitors: Design, Synthesis, and Comprehensive In Vitro and In Silico Evaluation for Potential Anticancer Activity." Pharmaceuticals (14248247) 19, no. 1 (2026): 50. https://doi.org/10.3390/ph19010050.

MLA (9th ed.) Citation

Sever, Belgin, et al. "Hydrazonylthiazole Derivatives as Dual EGFR and ALR2 Inhibitors: Design, Synthesis, and Comprehensive In Vitro and In Silico Evaluation for Potential Anticancer Activity." Pharmaceuticals (14248247), vol. 19, no. 1, 2026, p. 50, https://doi.org/10.3390/ph19010050.